论文部分内容阅读
<正> Purpose: To evaluate the additive effects of carteolol, a nonse-lective beta-blocker, and nipradilol, a newly developed alpha/beta- blocker, when used with latanoprost to lower the intraocular pressure (IOP) in glaucoma patients. Design: Open la